Balance Point Capital backs SG Homecare acquisition
By HME News Staff
Updated 10:44 AM CDT, Tue May 21, 2024
WESTPORT, Conn. – Balance Point Capital, an alternative investment manager focused on the lower-middle market, has announced its investment in SG Homecare. Balance Point, in conjunction with affiliate funds Balance Point Capital Partners V and Balance Point Capital Partners VI, arranged debt financing to support SG Homecare’s recent acquisition of Western Drug, retire existing debt and provide capital for future working capital needs. “Balance Point is excited to support SG’s continued growth and the acquisition of Western,” said Adam Sauerteig, partner at Balance Point. “Through this combination, SG has further strengthened its position as a leading DME provider in California. The combination of both SG and Western provides a clear value proposition within the DME space in conjunction with significant synergies and operating efficiencies.” SG Homecare, a portfolio company of Boston-based private equity firm Sverica Capital, has 16 locations throughout California. It announced its acquisition of Western Drug, which has nine locations in southern California, earlier in May.
Comments